Form 8-K - Current report:
SEC Accession No. 0001193125-25-132850
Filing Date
2025-06-02
Accepted
2025-06-02 08:43:28
Documents
16
Period of Report
2025-06-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d39702d8k.htm   iXBRL 8-K 49381
2 EX-3.1 d39702dex31.htm EX-3.1 7141
3 EX-3.2 d39702dex32.htm EX-3.2 63668
4 EX-99.1 d39702dex991.htm EX-99.1 13579
8 GRAPHIC g39702dsp25.jpg GRAPHIC 4632
  Complete submission text file 0001193125-25-132850.txt   286621

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA blue-20250602.xsd EX-101.SCH 2861
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE blue-20250602_lab.xml EX-101.LAB 17979
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blue-20250602_pre.xml EX-101.PRE 11265
18 EXTRACTED XBRL INSTANCE DOCUMENT d39702d8k_htm.xml XML 3710
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 251013245
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)